Your browser doesn't support javascript.
loading
Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma.
Wood, Andrew C; Krytska, Kateryna; Ryles, Hannah T; Infarinato, Nicole R; Sano, Renata; Hansel, Theodore D; Hart, Lori S; King, Frederick J; Smith, Timothy R; Ainscow, Edward; Grandinetti, Kathryn B; Tuntland, Tove; Kim, Sunkyu; Caponigro, Giordano; He, You Qun; Krupa, Shiva; Li, Nanxin; Harris, Jennifer L; Mossé, Yaël P.
Afiliación
  • Wood AC; Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
  • Krytska K; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Ryles HT; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Infarinato NR; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Sano R; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Hansel TD; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Hart LS; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • King FJ; Genomics Institute of the Novartis Research Foundation, San Diego, California.
  • Smith TR; Genomics Institute of the Novartis Research Foundation, San Diego, California.
  • Ainscow E; Genomics Institute of the Novartis Research Foundation, San Diego, California.
  • Grandinetti KB; Genomics Institute of the Novartis Research Foundation, San Diego, California.
  • Tuntland T; Genomics Institute of the Novartis Research Foundation, San Diego, California.
  • Kim S; Novartis Institutes of Biomedical Research, Cambridge, Massachusetts.
  • Caponigro G; Novartis Institutes of Biomedical Research, Cambridge, Massachusetts.
  • He YQ; Genomics Institute of the Novartis Research Foundation, San Diego, California.
  • Krupa S; Novartis Institutes of Biomedical Research, Cambridge, Massachusetts.
  • Li N; Genomics Institute of the Novartis Research Foundation, San Diego, California.
  • Harris JL; Genomics Institute of the Novartis Research Foundation, San Diego, California.
  • Mossé YP; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. mosse@email.chop.edu.
Clin Cancer Res ; 23(11): 2856-2868, 2017 Jun 01.
Article en En | MEDLINE | ID: mdl-27986745
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Tirosina Quinasas Receptoras / Quinasa 4 Dependiente de la Ciclina / Quinasa 6 Dependiente de la Ciclina / Neuroblastoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Nueva Zelanda
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Tirosina Quinasas Receptoras / Quinasa 4 Dependiente de la Ciclina / Quinasa 6 Dependiente de la Ciclina / Neuroblastoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Nueva Zelanda